MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer.
Amy J TibboAndrew HartleyRicha VasanRobin ShawLaura GalbraithErnest MuiHing Y LeungOwen J SansomPublished in: British journal of cancer (2023)
MBTPS2 is implicated in progressive prostate cancer and may mechanistically involve its effects on fatty acid and cholesterol metabolism.